PUBLIC HEALTH ASPECTS – MISUSE AND INAPPROPRIATE USE OF ANTIBIOTICS
Abstract
Introduction/Aim: Since their discovery, antibiotics have represented a key defense against bacterial infections, but an increasing number of strains are developing resistance through spontaneous genetic mutations and the acquisition of resistance genes, a process further stimulated by their improper and frequent use. This literature review encompasses studies published between 2010 and 2024 and analyzes four key areas: the misuse and inappropriate application of antibiotics, the development of superbugs, the global aspects of antimicrobial resistance (AMR), and preventive strategies with an emphasis on the role of vitamins. This review aims to present evidence on antibiotic misuse, resistance development, and preventive strategies, with particular attention to the importance of vitamins in maintaining immunity and improving the functioning of healthcare systems.
Methods: This literature review includes studies published from 2010 to 2024, focusing on the analysis of antibiotic misuse, the development of superbugs, the global impact of AMR, and the role of vitamins in prevention strategies.
Results: The results indicate that the most common causes of inadequate therapy are self-medication, prescription without microbiological confirmation, and poor communication between physicians and patients. AMR has been recognized as one of the greatest threats to public health, with significant consequences for morbidity, mortality, and healthcare system costs. Preventive measures include education of healthcare professionals and the general population, regulation of antibiotic sales, the development of new diagnostic and therapeutic methods, and the promotion of healthy lifestyle habits. Of particular importance are vitamins with antioxidant properties (retinol, tocopherol, and L-ascorbic acid), which may reduce the need for antibiotics, especially with the contribution of vitamin D, known to stimulate the immune system.
Conclusion: An integrated approach, in line with the One Health concept, is crucial for preserving the effectiveness of existing drugs and reducing the public health burden caused by AMR.
References
Baran A, Kwiatkowska A, Potocki L. Antibiotics and bacterial resistance-a short story of an endless arms race. Int J Mol Sci. 2023 Mar 17;24(6):5777. doi: 10.3390/ijms24065777.
Muteeb G, Rehman MT, Shahwan M, Aatif M. Origin of antibiotics and antibiotic resistance, and their impacts on drug development: a narrative review. Pharmaceuticals (Basel). 2023 Nov 15;16(11):1615. doi: 10.3390/ph16111615.
Tang KWK, Millar BC, Moore JE. Antimicrobial resistance (AMR). Br J Biomed Sci. 2023 Jun 28; 80:11387. doi: 10.3389/bjbs.2023.11387.
Koprivica M, Đekić Malbaša J. Epidemiološke karakteristike infekcija izazvanih toksinima bakterije Clostridioides difficile. Srp Arh Celok Lek.. 2024;152(9-10):505-8. doi: 10.2298/SARH240625077K.
Goggin K, Hurley EA, Lee BR, Bradley-Ewing A, Bickford C, Pina K, et al. Let's talk about antibiotics: a randomised trial of two interventions to reduce antibiotic misuse. BMJ Open. 2022 Nov 21;12(11): e049258. doi: 10.1136/bmjopen-2021-049258.
Serena TE, Gould L, Ousey K, Kirsner RS. Reliance on clinical signs and symptoms assessment leads to misuse of antimicrobials: post hoc analysis of 350 chronic wounds. Adv Wound Care (New Rochelle). 2022 Dec;11(12):639-49. doi: 10.1089/wound.2021.0146.
Katundu D, Chussi D, Nyombi B, Philemon R, Semvua H, Hannink G, et al. Effect of placebo versus prophylactic postoperative amoxicillin on post-(adeno) tonsillectomy morbidity in Tanzanian children: a two-centre, double-blind randomized controlled non-inferiority trial. Pan Afr Med J. 2022 Jun 22;42:142. doi: 10.11604/pamj.2022.42.142.35540.
Or PL, Ching TY. The effectiveness of raising Hong Kong parents' awareness of antimicrobial resistance through an education program with peer support on social media: a randomized, controlled pilot study. BMC Public Health. 2022 Feb 15;22(1):315. doi: 10.1186/s12889-022-12697-w.
Goggin K, Bradley-Ewing A, Myers AL, Lee BR, Hurley EA, Delay KB, et al. Protocol for a randomised trial of higher versus lower intensity patient-provider communication interventions to reduce antibiotic misuse in two paediatric ambulatory clinics in the USA. BMJ Open. 2018 May 9;8(5):e020981. doi: 10.1136/bmjopen-2017-020981.
Williams DJ, Creech CB, Walter EB, Martin JM, Gerber JS, Newland JG, et al. Short- vs standard-course outpatient antibiotic therapy for community-acquired pneumonia in children: the SCOUT-CAP randomized clinical trial. JAMA Pediatr. 2022 Mar 1;176(3):253-61. doi: 10.1001/jamapediatrics.2021.5547.
Fricker Z, Jiang G, Patel H, McLaughlin A, Izunza Barba S, Niezen S, et al. A randomized study of ceftriaxone for the prevention of infections in hospitalized patients with advanced cirrhosis. Hepatol Commun. 2024 Jan 5;8(1):e0356. doi: 10.1097/HC9.0000000000000356.
McNally D, Simpson M, Morris C, Shephard A, Goulder M. Rapid relief of acute sore throat with AMC/DCBA throat lozenges: randomised controlled trial. Int J Clin Pract. 2010 Jan;64(2):194-207. doi: 10.1111/j.1742-1241.2009.02230.x.
Lodi G, Azzi L, Varoni EM, Pentenero M, Del Fabbro M, Carrassi A, et al. Antibiotics to prevent complications following tooth extractions. Cochrane Database Syst Rev. 2021 Feb 24;2(2):CD003811. doi: 10.1002/14651858.CD003811.pub3.
Bhuvaraghan A, King R, Larvin H, Aggarwal VR. Antibiotic use and misuse in dentistry in India: a systematic review. Antibiotics (Basel). 2021 Nov 26;10(12):1459. doi: 10.3390/antibiotics10121459.
Bert F, Previti C, Calabrese F, Scaioli G, Siliquini R. Antibiotics self-medication among children: a systematic review. Antibiotics (Basel). 2022 Nov 9;11(11):1583. doi: 10.3390/antibiotics11111583.
Bi B, Qin J, Zhang L, Lin C, Li S, Zhang Y. Systematic review and meta-analysis of factors influencing self-medication in children. Inquiry. 2023 Jan-Dec;60:469580231159744. doi: 10.1177/00469580231159744.
Almohammed RA, Bird EL. Public knowledge and behaviours relating to antibiotic use in Gulf Cooperation Council countries: a systematic review. J Infect Public Health. 2019 Mar-Apr;12(2):159-66. doi: 10.1016/j.jiph.2018.09.002.
Duan L, Lin R, Wang D, Wang X, Zhang X, Ding L, et al. Eliciting parents' decision-making to antibiotic use for upper respiratory tract infections: A discrete choice experiment. J Glob Health. 2024 Dec 9;14:04220. doi: 10.7189/jogh.14.04220.
Palleja A, Mikkelsen KH, Forslund SK, Kashani A, Allin KH, Nielsen T, et al. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nat Microbiol. 2018 Nov;3(11):1255-65. doi: 10.1038/s41564-018-0257-9.
Schwartz DJ, Langdon AE, Dantas G. Understanding the impact of antibiotic perturbation on the human microbiome. Genome Med. 2020 Sep 28;12(1):82. doi: 10.1186/s13073-020-00782-x.
Konstantinidis T, Tsigalou C, Karvelas A, Stavropoulou E, Voidarou C, Bezirtzoglou E. Effects of Antibiotics upon the Gut Microbiome: A Review of the Literature. Biomedicines. 2020 Nov 16;8(11):502. doi: 10.3390/biomedicines8110502.
Duan H, Yu L, Tian F, Zhai Q, Fan L, Chen W. Antibiotic-induced gut dysbiosis and barrier disruption and the potential protective strategies. Crit Rev Food Sci Nutr. 2022;62(6):1427-52. doi: 10.1080/10408398.2020.1843396.
McDonnell L, Gilkes A, Ashworth M, Rowland V, Harries TH, Armstrong D, et al. Association between antibiotics and gut microbiome dysbiosis in children: systematic review and meta-analysis. Gut Microbes. 2021 Jan-Dec;13(1):1-18. doi: 10.1080/19490976.2020.1870402.
Patrick DM, Sbihi H, Dai DLY, Al Mamun A, Rasali D, Rose C, et al. Decreasing antibiotic use, the gut microbiota, and asthma incidence in children. Lancet Respir Med. 2020 Nov;8(11):1094-105. doi: 10.1016/S2213-2600(20)30052-7.
Majumder MAA, Rahman S, Cohall D, Bharatha A, Singh K, Haque M, et al. Antimicrobial stewardship: fighting antimicrobial resistance and protecting global public health. Infect Drug Resist. 2020 Dec 29;13:4713-38. doi: 10.2147/IDR.S290835.
Rajput A. Examining the implementation and effectiveness of antibiotic stewardship programs in healthcare settings to prevent antibiotic resistance and promote prudent antibiotic use. Knowl Res. 2023 Jun 30;1(11):11-24. doi: 10.57067/kr.v1i11.95.
Theodorakis N, Feretzakis G, Hitas C, Kreouzi M, Kalantzi S, Spyridaki A, et al. Antibiotic resistance in the elderly: mechanisms, risk factors, and solutions. Microorganisms. 2024 Sep 30;12(10):1978. doi: 10.3390/microorganisms12101978.
World Health Organization [Internet]. Antimicrobial resistance and the United Nations sustainable development cooperation framework: guidance for United Nations country teams. Geneva: WHO. 2021 [cited 2025 Jun 13]. Available from: https://books.google.com/books?id=k3dyEAAAQBAJ
Arnold KE, Laing G, McMahon BJ, Fanning S, Stekel DJ, Pahl O, et al. The need for One Health systems-thinking approaches to understand multiscale dissemination of antimicrobial resistance. Lancet Planet Health. 2024 Feb;8(2):e124-33. doi: 10.1016/S2542-5196(23)00278-4.
Gray DA, Wenzel M. Multitarget approaches against multiresistant superbugs. ACS Infect Dis. 2020 Jun 12;6(6):1346-65. doi: 10.1021/acsinfecdis.0c00001.
Ramirez J, Guarner F, Bustos Fernandez L, Maruy A, Sdepanian VL, Cohen H. Antibiotics as major disruptors of gut microbiota. Front Cell Infect Microbiol. 2020 Nov 24;10:572912. doi: 10.3389/fcimb.2020.572912.
Kim MC, Cullum R, Hebishy AMS, Mohamed HA, Faraag AHI, Salah NM, et al. Mersaquinone, a new tetracene derivative from the marine-derived Streptomyces sp. EG1 exhibiting activity against methicillin-resistant Staphylococcus aureus (MRSA). Antibiotics (Basel). 2020 May 14;9(5):252. doi: 10.3390/antibiotics9050252.
Mitchell J, Cooke P, Ahorlu C, Arjyal A, Baral S, Carter L, et al. Community engagement: the key to tackling antimicrobial resistance (AMR) across a One Health context? Glob Public Health. 2022 Nov;17(11):2647-64. doi: 10.1080/17441692.2021.2003839.
Koprivica M, Bjelanović J. Hipervitaminoza B12. Med Čas. 2021;55(4):139-43. doi: 10.5937/mckg55-33665.
Koprivica M, Bjelanović J. Značaj vitamina A u ishrani. Med Čas. 2021;55(3):99-103. doi: 10.5937/mckg55-31633.
Koprivica M, Miljković A. Uticaj vitamina E na različite organske sisteme. Sanamed. 2024;19(2):215-9. doi: 10.5937/sanamed0-49398.
Hemilä H, Chalker E. Vitamin C reduces the severity of common colds: a meta-analysis. BMC Public Health. 2023 Dec 11;23(1):2468. doi: 10.1186/s12889-023-17229-8.
Koprivica M, Kašiković Lečić S. Uzroci, posledice i lečenje nedostatka vitamina D kod ljudi. Med Čas. 2023;57(3):119-24. doi: 10.5937/mckg57-43860.
Koprivica M, Miljković A. Javnozdravstveni aspekti vitamina D. Srp Arh Celok Lek. 2025;153(1-2):103-6. doi: 10.2298/SARH241123012K.
Council of the European Union. Council recommendation on stepping up EU actions to combat antimicrobial resistance in a One Health approach. Off J Eur Union [Internet]. 2023 Jun 22 [cited 2025 Jun 13];60(C220/1): 6-9. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv%3AOJ.C_.2023.220.01.0001.01.ENG&toc=OJ%3AC%3A2023%3A220%3ATOC
